Related Experiment Video
Updated: Jun 1, 2026
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Outcomes of epiretinal membrane removal in eyes with and without concurrent vision-limiting ocular disease
Elad Moisseiev1, Zvi Davidovitch, Anat Loewenstein
1Department of Ophthalmology, Tel Aviv Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. elad_moi@netvision.net.il
Purpose:
To evaluate preoperative and intraoperative parameters in patients who underwent pars plana vitrectomy (PPV) for epiretinal membrane (ERM) removal and identify prognostic factors for visual recovery and complications. Furthermore, eyes with and without additional vision-limiting ocular disease were compared.
Methods:
Ninety eyes of 90 patients who underwent PPV and ERM peeling were included in this retrospective study. Patients were divided according to the presence of additional vision-limiting conditions.
Results:
The mean visual acuity (VA) improvement was -0.156 logMAR. No parameter was found to correlate with the final VA or postoperative complications. Thirty-four patients (37.8%) had concurrent vision-limiting ocular conditions. Although these eyes had lower initial and final VA, there was no significant difference in VA improvement between them and eyes without concurrent disease.
Conclusions:
PPV and membrane peeling is an effective treatment for patients with ERM, even in the presence of concurrent vision-limiting ocular disease.